v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net loss $ (2,133,208) $ (1,415,979)
Adjustments to reconcile net loss to net cash used in operating activities:    
 Accrued interest, notes payable 117,415 160,733
 Gain on derivative liability 140,043 94,374
 Loss on settlement of notes payable 5,033
 Share professional fees/compensation 392,051
 Loss (Gain) on disposal of investment 15,000 120,000
 Gain on disposal of subsidiary 69,243
 Depreciation and amortization 17,136 8,807
Changes in operating assets and liabilities:    
 Inventory 160,492
 Other receivables (6,000) 30,000
 Accounts payable and accrued expenses 751,309 455,655
Net cash used in operating activities (1,029,062) 11,166
Cash flows from investing activities    
Deposits on acquistions (358,261) (805,000)
Net cash provided by investing activities (358,261) (805,000)
Cash flows from financing activities    
Payments to loans payable, related parties (137,640) (94,847)
Payments to convertible note payable (138,800)
Proceeds from warrant exercise 30,000
Proceeds from loans payable, related parties 148,573
Proceeds from notes payable 1,377,500
Proceeds from convertible notes payable 930,000
Proceeds from issuance of common stock 10,000
Net cash provided by financing activities 1,388,433 736,353
Net increase (decrease) in cash 1,110 (57,481)
Cash at beginning of period 6,938 64,419
Cash at end of period 8,048 6,938
Supplemental Cash Flow Information:    
Cash paid for interest 826
Cash paid for income taxes
Non-cash investing and financing information:    
Conversion of debt for common stock $ 34,000 $ 242,228